CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$84.78+10.38 (+13.95%)
Close on Nov 16, 2026Market cap $7.51BP/E –Yield –
CG Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CG Oncology's enterprise value was $5.39B on Nov 11, 2026, against $2.83B a year earlier. Over the last 3 years it ranged from $22.21M to $5.61B, with a median of $1.91B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.39B | +109.4% |
| 2025 | Dec 31, 2025 | $2.57B | +84.3% |
| 2024 | Dec 31, 2024 | $1.40B | – |
See a number that looks wrong?